Smith to Deepen Strategic Leadership and Complement Commercial, Operational and Financial Expertise of the BoardCAMBRIDGE, Mass., April 16, 2020 (GLOBE […]
Phase 1b trial with intranasal betahistine for prevention of antipsychotic-induced weight gain progressing towards final read-outPhase 2 trial with intranasal […]
MONTREAL, April 16, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, announced […]